Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Zoetis faces class action over alleged misleading claims on key animal health products.

Market News
28 May 2026
PRNewsWire
View Source
Bearish
pluang ai news

A class action lawsuit has been filed against Zoetis Inc. for allegedly misleading investors about the performance of its main animal health products, including Librela, Simparica Trio, Apoquel, and Cytopoint. The complaint claims Zoetis failed to disclose weakening sales and market share losses due to safety concerns and competition. The truth emerged through multiple disclosures from August 2025 to May 2026, culminating in a sharp 21.5% stock price drop after poor Q1 2026 results and lowered guidance. Investors who bought Zoetis securities between January 2025 and May 2026 may join the class action, with a lead plaintiff deadline of July 27, 2026.

More News (ZTS)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App